The PROSPER trial: chemotherapy-related endpoints in patients with nonmetastatic castration-resistant prostate cancer treated with enzalutamide

Neal Shore, Fred Saad, Maha Hussain, Karim Fizazi, Per Rathenborg, Eren Demirhan, Katharina Modelska, De Phung, Andrew Krivoshik, Cora N Sternberg

OriginalsprogEngelsk
Publikationsdato18 maj 2018
StatusUdgivet - 18 maj 2018
BegivenhedAUA 2018 - San Francisco, USA
Varighed: 18 maj 201821 maj 2018

Konference

KonferenceAUA 2018
Land/OmrådeUSA
BySan Francisco
Periode18/05/201821/05/2018

Citationsformater